Bill McEwen3h
New FDA Rules for TV Drug Ads: Simpler Language and No Distractions
FDA's new rules aim to make drug ads clearer and more transparent, addressing long-standing concerns about risk information ...
NBC News7d
FDA proposes ending use of decongestant found in many cold, allergy medicines
The Food and Drug Administration on Thursday proposed ending the use of a common ingredient found in many popular over-the-counter cold and allergy medications. The agency said an extensive ...
Food Safety News6d
FDA updates Food Code for the 50 states
The U.S. Food and Drug Administration has published the 2022 Food Code Supplement. The Supplement updates the 2022 Food Code with recommendations from regulatory officials, industry, academia ...
Food Safety News7d
FDA identifies new outbreak of E. coli
The investigation is in its early stages, and 33 patients have been discovered. The Food and Drug Administration has not released any patient information, such as where the patients live or their ...
News Medical10d
Key FDA Decisions Made in 2024
In February 2024, the U.S. FDA approved Aurlumyn (iloprost), an injectable vasodilator treatment that is the first ever to be approved for the treatment of severe frostbite. This approval was ...
STAT10d
A Q&A with the FDA’s top vaccine regulator amid a fresh wave of disinformation
At a public forum last week, Peter Marks, the top vaccine regulator for the Food and Drug Administration, said the way to counter the movement is by being transparent. “We have to be steadfast ...
Today6d
FDA moves to pull popular cold and flu medicines from shelves
The FDA is proposing many popular over-the-counter cold and allergy medications be removed from store shelves. The agency says a common ingredient they share, oral phenylephrine, doesn’t ...
Business Insider10d
Journey Medical announces U.S. FDA approval of Emrosi
Journey Medical (DERM) announced that the FDA has approved Emrosi, formerly referred to as DFD-29, for the treatment of inflammatory lesions of rosacea in adults. Emrosi was developed in ...
Business Insider3d
Syncona : Autolus Receives FDA Approval For AUCATZYL In Adults With Relapsed/Refractory B-ALL
(RTTNews) - Syncona Ltd (SYNC.L) said that its portfolio company Autolus Therapeutics announced that the U.S. Food and Drug Administration has granted marketing approval for AUCATZYL (obe-cel ...
Kraft Heinz must face Mac & Cheese lawsuit, judge rules
In a decision on Wednesday, U.S. District Judge Mary Rowland said the Illinois, California and New York consumers leading the lawsuit plausibly alleged that Kraft Mac & Cheese contained a synthetic ...
Morningstar9d
Merus: FDA Extends Review of Cancer Drug Zenocutuzumab to February
Merus on Tuesday said the Food and Drug Administration extended its review of the clinical-stage oncology company's proposed zenocutuzumab cancer treatment. Merus said the FDA set a new target ...